Search Results - "Pendse, Deepa"

Phase II study of everolimus in metastatic urothelial cancer by Milowsky, Matthew I., Iyer, Gopa, Regazzi, Ashley M., Al‐Ahmadie, Hikmat, Gerst, Scott R., Ostrovnaya, Irina, Gellert, Lan L., Kaplan, Rana, Garcia‐Grossman, Ilana R., Pendse, Deepa, Balar, Arjun V., Flaherty, Anne Marie, Trout, Alisa, Solit, David B., Bajorin, Dean F.

“…What's known on the subject? and What does the study add? No recent advances have been made in the treatment of patients with advanced bladder cancer and, to…”
Get full text

Evaluating the association of multiple single nucleotide polymorphisms with response to gemcitabine and platinum combination chemotherapy in urothelial carcinoma of the bladder by Alanee, Shaheen R, Shah, Sohela, Zabor, Emily C, Vijai, Joseph, Ostrovnaya, Irina, Garcia-Grossman, Ilana R, Pendse, Deepa V, Littman, Jason, Regazzi, Ashley M, Offit, Kenneth, Bajorin, Dean F

“…To examine germline single nucleotide polymorphisms (SNPs) as markers of response to gemcitabine platinum (GP) combination chemotherapy in urothelial carcinoma…”
Get full text

Exome sequencing of extreme phenotypes to identify variants predictive of response to chemotherapy in bladder cancer by Alanee, Shaheen, Shah, Sohela, Stratton, Kelly Lynn, Garcia-Grossman, Ilana Rebecca, Zabor, Emily, Ostrovnaya, Irina, Joseph, Vijai, Pendse, Deepa, Bajorin, Dean F., Offit, Kenneth

“…Abstract only 300 Background: Little is known about germline variants predictive of response to chemotherapy in bladder cancer (BC). We investigated germline…”
Get full text

Phase II trial of neoadjuvant gemcitabine (G) and cisplatin (C) with sunitinib in patients (pts) with muscle-invasive bladder cancer (MIBC) by Balar, Arjun Vasant, Iyer, Gopa, Apolo, Andrea Borghese, Regazzi, Ashley Marie, Garcia-Grossman, Ilana Rebecca, Pendse, Deepa, Ostrovnaya, Irina, Chou, Joanne F., Bochner, Bernard, Dalbagni, Guido, Herr, Harry W., Milowsky, Matthew I., Bajorin, Dean F.

“…Abstract only 4581^ Background: Response to neoadjuvant chemotherapy (NC) prior to radical cystectomy (RC) predicts improved overall survival (OS) in MIBC…”
Get full text

Alterations in the PI3K/Akt signaling pathway and association with outcome in invasive high-grade urothelial cancer (UC) by Balar, Arjun Vasant, Iyer, Gopa, Al-Ahmadie, Hikmat, Janakiraman, Manickam, Ostrovnaya, Irina, Regazzi, Ashley Marie, Garcia-Grossman, Ilana Rebecca, Pendse, Deepa, Bochner, Bernard, Bajorin, Dean F., Milowsky, Matthew I., Solit, David B.

“…Abstract only 277 Background: Activating mutations in PIK3CA have been associated with improved outcomes in patients (pts) with breast cancer (Kalinsky, Clin…”
Get full text

Single nucleotide polymorphisms as markers of bacillus Calmette-Guérin intravesical therapy response in non-muscle invasive bladder cancer by Alanee, Shaheen, Hamilton, Robert James, Joseph, Vijai, Ostrovnaya, Irina, Garcia-Grossman, Ilana Rebecca, Gallagher, David J, Pendse, Deepa, Regazzi, Ashley Marie, Przybylo, Jennifer A., Gaudet, Mia, Milowsky, Matthew I., Herr, Harry W., Offit, Kenneth, Bajorin, Dean F.

“…Abstract only e15022 Background: A marker of response to Bacillus Calmette-Guérin (BCG) intravesical therapy in high-risk non-muscle invasive bladder cancer…”
Get full text